Chris Lewis
Stock Analyst at Roth Capital
(3.09)
# 1,207
Out of 4,876 analysts
13
Total ratings
77.78%
Success rate
62.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chris Lewis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGNT Cognyte Software | Reinstates: Buy | $4 | $9.11 | -56.09% | 5 | Nov 8, 2017 | |
| IRMD IRADIMED CORPORATION | Reinstates: Buy | $16 | $60.84 | -73.70% | 3 | Oct 31, 2017 | |
| AXGN Axogen | Initiates: Buy | $15 | $10.50 | +38.10% | 1 | Mar 6, 2017 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $53.65 | - | 3 | Feb 22, 2017 | |
| IRIX IRIDEX | Initiates: Buy | $20 | $0.89 | +2,138.14% | 1 | Dec 21, 2016 |
Cognyte Software
Nov 8, 2017
Reinstates: Buy
Price Target: $4
Current: $9.11
Upside: -56.09%
IRADIMED CORPORATION
Oct 31, 2017
Reinstates: Buy
Price Target: $16
Current: $60.84
Upside: -73.70%
Axogen
Mar 6, 2017
Initiates: Buy
Price Target: $15
Current: $10.50
Upside: +38.10%
Exact Sciences
Feb 22, 2017
Upgrades: Buy
Price Target: n/a
Current: $53.65
Upside: -
IRIDEX
Dec 21, 2016
Initiates: Buy
Price Target: $20
Current: $0.89
Upside: +2,138.14%